Scilex Holding to Invest $150M in Datavault AI for Growth and Expansion.

Scilex Holding plans to invest $150M in bitcoin into Datavault AI. The investment aims to fund Datavault's growth by accelerating its supercomputing infrastructure, expanding independent data exchanges, and unlocking new revenue streams. This move is expected to benefit both companies and expand their offerings in the tech industry.

Scilex Holding Company (Nasdaq: SCLX) has announced a strategic $150 million Bitcoin investment in Datavault AI Inc. (Nasdaq: DVLT), aimed at funding Datavault's growth by accelerating its supercomputing infrastructure, expanding independent data exchanges, and unlocking new revenue streams. The investment, which will be executed in two tranches, signals a significant pivot for Scilex into the data monetization market, projected to reach $30-50 billion by 2024.

Under the agreement, Scilex will receive up to 278,914,094 shares of Datavault common stock at an effective price of $0.5378 per share. The first tranche of 15 million shares will be issued at closing, with the remainder to be issued as a pre-funded warrant following shareholder approval. Scilex will gain board representation rights, with the ability to nominate two directors while maintaining 10% ownership or one director at 5-10% ownership.

The strategic rationale behind this investment appears focused on capturing value in the biotech data monetization market, which is expected to reach a market size of $30-50 billion by 2024. Scilex aims to leverage Datavault's blockchain and AI capabilities to create a marketplace for tokenized real-world biotech assets, connecting Scilex to a broader AI market projected to reach $1.8 trillion by 2030.

This investment represents an emerging trend of cryptocurrency integration into mainstream corporate finance and strategy. The use of Bitcoin for such a significant corporate transaction, rather than traditional currency, signals Scilex's embrace of cryptocurrency in corporate treasury operations. The decision to utilize Bitcoin for this transaction is notable for its potential to reduce transaction costs and increase transparency in the financial system.

Henry Ji, Ph.D., CEO, President, and Chairman of the Board of Scilex Holding Company, stated, "Datavault's cutting-edge technologies align perfectly with the biotech sector's need for advanced data analytics, AI-driven insights, and supercomputing power. This investment reflects our belief in Datavault’s ability to transform markets where trust and precision are critical."

The strategic investment is intended to capture growth in the biotech data monetization market, which is expected to reach a market size of $30-50 billion by 2024. Scilex intends to leverage its expertise in the biotech and pharmaceutical space to create a potential marketplace for Real-World Assets (RWA) in the biotech and pharmaceutical industry that are tokenized on a blockchain to represent their ownership in digital form.

The transaction will occur in two tranches, with 15 million shares issued at initial closing and the remainder through a pre-funded warrant pending stockholder approval. Scilex will gain meaningful governance influence through board nomination rights – two directors while maintaining 10% ownership and one director at 5-10% ownership.